Canada: Canada’s Competition Bureau Releases Updated IP Enforcement Guidelines And White Paper On Patent Litigation Settlement Agreements

The Competition Bureau made several significant announcements in September that affect the pharmaceuticals and life sciences sectors.

On September 18, 2014, the Bureau released the final version of its updated Intellectual Property Enforcement Guidelines (IPEGs), which set out the bureau's approach to navigating the intersection of competition law and intellectual property. Of perhaps greater import, the following week the bureau released a white paper, Patent Litigation Settlement Agreements: A Canadian Perspective, which provides the bureau's first in-depth statement on how it may analyze so-called "pay for delay" settlements under the Competition Act (Act).


As noted in our April 2014 Pharma in brief, the bureau's IPEGs revisions are intended to occur in two phases. The first phase, now complete with the publication of the September 2014 version, involved public consultations on a draft update released in April. This version does not represent a material departure in the approach adopted in 2000 when the IPEGs were first released. The bureau has maintained its position that the circumstances in which it may apply the Act to conduct involving IP or IP rights fall into two broad categories:

  • those involving something more than the mere exercise of the IP right, and
  • those involving the mere exercise of the IP right and nothing else.

The bureau will use the Act's general provisions to address the former circumstances and section 32 (special remedies) to address the latter.

There are several new elements in the September 2014 version, most notably, a reworked discussion of patent pooling arrangements as well as a new discussion of product switching.

It is expected that phase two of the revisions will seek further public comment on additional updates to the IPEGs that will include the bureau's approach to patent litigation settlements, patent assertion entities, and activities related to standard essential patents.

Patent litigation settlements

In conjunction with a keynote address by Commissioner of Competition John Pecman at a pharmaceutical industry conference, the bureau released a white paper that provides background information on the pharmaceutical industry in Canada, the regulatory regime in Canada, the Competition Act provisions that may apply to reverse-payment settlement agreements, and the bureau's preliminary views as to how the Act could apply to such settlements.  

Commissioner Pecman (at least on paper) struck a defiant tone in announcing the bureau's approach to reverse-payment settlements, noting he "completely disagreed" with commentators who have noted that Canada's different regulatory regime merits a "less vigorous" approach to these agreements than in the United States or the European Union. As well, he acknowledged that many would find the bureau's approach "somewhat surprising, particularly in light of the US Supreme Court's recent decision in Actavis."

The white paper's most significant elements are the acknowledgment that the bureau will examine reverse-payment settlement agreements under both the criminal and civil provisions of the Act, and the bureau's call for a notification regime similar to that which exists in the United States.

Application of the Act to Reverse Settlement Agreements

When the US Supreme Court addressed reverse-payment settlements in its Actavis decision, the court found they were subject to a "rule of reason" analysis, which is to say they are not automatically considered anti-competitive, but instead one must examine the likely competitive effects of the agreement. The bureau has adopted a "decidedly different view," according to Commissioner Pecman. The white paper makes clear that the bureau will evaluate settlements under the per se "criminal conspiracy" provision or the "civil abuse of dominance" or "civil agreements with competitors" provisions.

The commissioner said the following settlements would likely attract scrutiny under the criminal provisions:

  • "If a settlement is between competitors and includes conduct with respect to markets or products that are not the focus of the patent litigation or the conduct is beyond the scope of the patent, such as fixing a generic entry date beyond the term of the patent, provided that the conduct is of the type prohibited by this provision."
  • "If there is direct or circumstantial evidence that indicates that the settlement is a vehicle for a 'naked restraint' on competition that is not implemented in furtherance of a legitimate collaboration or was motivated by factors beyond the issues associated with the litigation."

Examples provided include where there is a payment for delayed entry by a generic, with the entry date after the patent's expiry date, or where it is clear that a payment is strictly to delay or prevent entry.

By contrast, where there is no evidence of a "naked restraint," the bureau would most likely review the matter under the civil "agreements between competitors" provision. In certain circumstances, where it appears the parties are abusing their dominant position in a market, the bureau would proceed under the "abuse of dominance" provisions. In both instances, the bureau would need to demonstrate that the settlement agreement would likely cause a substantial lessening or prevention of competition.

Notification system

The bureau attributes its lack of enforcement activity in this area in part to the absence of a notification regime in Canada by which settling parties must advise the government of the settlement. Such a system exists in the United States, where settling parties must file copies of the agreements and provide detailed descriptions of the terms of settlement. The white paper notes that the lack of such a system in Canada "could lead to potentially anticompetitive settlements evading review under the Act," while adopting such a system "would allow us to better protect consumers."

In his remarks, Commissioner Pecman said he will "advocate for better information on patent settlements and the need to explore approaches that could be adapted to Canada's regulatory framework." One is left to wonder whether, in light of the Harper government's stated priority of defending Canadian consumers, legislation to provide for a notification regime can be expected in the government's next budget bill, expected in the spring of 2015. This government has shown a willingness to use omnibus budget legislation to make significant changes to the Competition Act.

In the event a notification regime is adopted, it could have a significant impact on how pharmaceutical companies approach patent litigation settlements in Canada. For those firms operating in North American, its impact may be minimal if they already structure Canadian settlements in a manner similar to contemporaneous US settlements. However, given the differences in Canada's legal regime and the commissioner's remarks, it will remain important to continue to carefully analyze any Canadian settlement to ensure compliance with the Competition Act.


The updated IPEGs may be found here

The Bureau's White Paper on Patent Litigation Settlements may be found here

Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global legal practice. We provide the world's pre-eminent corporations and financial institutions with a full business law service. We have more than 3800 lawyers based in over 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

Norton Rose Fulbright LLP, Norton Rose Fulbright Australia, Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South Africa (incorporated as Deneys Reitz Inc) and Fulbright & Jaworski LLP, each of which is a separate legal entity, are members ('the Norton Rose Fulbright members') of Norton Rose Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein helps coordinate the activities of the Norton Rose Fulbright members but does not itself provide legal services to clients.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions